跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
rosuvastatin + ezetimibe
首页
药物
rosuvastatin + ezetimibe
rosuvastatin + ezetimibe
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
US 11786526 B2
申请人: SANOFI SA
优先权: 2016
CN
EP
US
3 件公开
Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases
US 9763885 B2
申请人: ALTHERA LABORATORIES LTD
优先权: 2013
US
2 件公开
US 10376470 B2
申请人: ALTHERA LIFE SCIENCES LLC
优先权: 2017
US
Medical composition containing a cholesterol absorption inhibitor and cholesterol biosynthesis inhibitor
CN 105722505 A
申请人: EGYT GYOGYSZERVEGYESZETI GYAR
优先权: 2013
CN
2 件公开
Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
CN 102451161 A
申请人: LIYAN WANG
优先权: 2010
CN
Atherosclerotic Plaque Dissolution Composition
US 2011196383 A1
申请人: ATHEROLYSIS MEDICAL INC
优先权: 2011
US
Composite formulation for oral administration comprising ezetimibe and rosuvastatin
US 10434067 B2
申请人: HANMI PHARM IND CO LTD
优先权: 2013
US
PHARMACEUTICAL COMPOSITION
EP 3243506 A1
申请人: ADAMED SP ZOO
优先权: 2016
EP
Compound tablet containing ezetimibe and rosuvastatin and preparation method thereof
CN 107028906 A
申请人: JIANGSU FURUI BIOLOGICAL MEDICINE CO LTD
优先权: 2017
CN
PHARMACEUTICAL COMBINATION PREPARATION COMPRISING EZETIMIBE AND ROSUVASTATIN
CN 111886003 A
申请人: HANMI PHARM IND CO LTD
优先权: 2018
CN
Ezetimibe rosuvastatin calcium preparation and preparation method thereof
CN 117771248 A
申请人: NINGBO HIGH NEW DISTRICT MENOVO PHARMACEUTICAL INNOVATION RES INSTITUTE CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈